EUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020
|
|
- Harold Porter
- 5 years ago
- Views:
Transcription
1 EUROPE March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1
2 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA, Belgium Sabine Haubenreisser EMA, EU Lenita Lindström-Gommers European Commission, EU Kristin Raudsepp Medicines Agency, Estonia Thomas Senderovitz HMA, DKMA, Denmark Chris Walker Amgen, UK DIA Europe reflects DIA s Strategic initiatives on thought leadership. The Four Critical Cornerstone Areas: Regulatory Science Translational Science Value & Access Patient Engagement I 2
3 Thought Leadership Streams : 9 Topics designed to advance health care outcomes through innovation across 9 core thought leadership streams Clinical Development Data and Data Standards Patient Engagement Pharmacovigilance Regulatory Science Translational Medicines and Science Value and Access Medical Affairs Chemistry, Manufacturing and Control (CMC) I 3
4 Abstract Topics EVOLUTION OF THE REGULATORY SCIENCE STRATEGY & AGENDA KEEPING PACE WITH HEALTHCARE Catalysing the integration of science and technology in medicines development Driving collaborative evidence generation improving the scientific quality of evaluations, developing and coping with new kinds of evidence. Advancing patient-centred access to medicines in partnerships with healthcare systems Addressing emerging health threats and availability/therapeutic challenges - regulatory collaboration and convergence in the EU and beyond Enabling and leveraging research and innovation - how does this impact regulatory standards? Regulatory science academic community - overview of regulatory science network in Europe Quality of the European regulatory system: a global competitiveness assessment Corporate social responsibility Competitiveness performance of the EU pharmaceutical industry how to support the development REGULATORY OPERATIONS - TECHNOLOGY AND INFRASTRUCTURE TRANSFORMING HOW WE WORK Automatisation of regulatory processes in industry or regulatory agencies how can we use the technology for the better? Telematics strategy in practice impact on regulatory operations and submissions From e-pil to no-paper-pil pros and cons for replacing the PI on paper From paper to e-prescriptions Initiatives from NCAs and HMA Availability problems of medicinal products how to prevent and mitigate FROM PERSONALISED MEDICINES TO PERSONALISED HEALTHCARE - THE CHANGING EXPECTATIONS AND ROLE OF STAKEHOLDERS WITH PERSONALISED MEDICINES End to end R&D processes support Bioethics with novel technologies: CRISPR babies and beyond where are the limits? New data sources from new technologies: Gene editing, genome sequencing, rapid microbiological methods, digital endpoints, including clinical care data - what is needed to foster of access and acceptance? (e.g. fit-for-purpose data quality standards for RWD, healthcare data sharing) From indication-based labels to a new era of evidence generation what are the future roles of regulators and HTA bodies? Development challenges with small populations - what are the future concepts (e.g. CT designs, modelling & simulation, n=1, RWD) for regulators and HTA bodies? Learning Healthcare System - in the clouds or in practice? (e.g. advice along the development continuum, data analytics, cloud based assessments) The healthcare future is digital, genomic and collaborative - how can pharma, medical device and IVD pathways be integrated? Advanced therapies, novel technologies and personalisation of healthcare: Are transformative innovations and system efficiency incompatible? Incentivising the personalisation of care: What is the role of innovative pricing and reimbursement models? VALUE AND ACCESS - EMERGING TRENDS IN HTA AND MARKET ACCESS Why parallel advice is needed (HTA principles explained, the major EU HTA archetypes and why they have different requirements versus regulators)? Experience with parallel - SA, what works what doesn t and what is needed beyond 2020 What next for HTA post Streamlining the HTA assessment beyond EUnetHTA/ Future of HTA assessment or other value evaluation what fits the future therapies? Encouraging the use of RWE, Monitoring outcomes - Case studies from managed entry agreements in Europe what works, what doesn t? A patient centric approach to HTA - integrating patient voice into value discussions how do we get there? How to manage affordability - the tension between ever more exciting and relevant technologies and limited healthcare budgets. A joined up approach HTA and market access beyond pills and injectables, how to we allow for combination products integrating e-health, devices and diagostics? I 4
5 Abstract Topics ADVANCES IN CLINICAL SAFETY AND PHARMACOVIGILANCE PV automation - call for demos, cloud storage, etc. Automated processes for regulators Globalisation in PV Capacity building in PV The WEB-RADR 2 project: outcomes after 28 February 2020 EudraVigilance: Inspections and status quo after the implementation of the new system Patient involvement in development and safe use of medicines Falsified Medicine Directive: One year after implementation impact on safety and PV Medical Devices Regulation are you ready? Predictive safety safety biomarkers; systems pharmacology; network models; data pooling Mobile Apps / wearables oversight, regulations and requirements CLINICAL TRIALS - INNOVATIVE TRIAL DESIGN, EVIDENCE GENERATION AND PREPARING FOR THE CTR Clinical Trial Regulation: State of play at Member States level - Experiences and lessons learned from pilots Innovative early CTs: complex trial design - Experiences and challenges with running the innovative clinical trial with case studies from ATMPs Data Transparency in Clinical Trials Clinical Trial Facilitation Group (CTFG) updates New Clinical Trial Regulation are we ready? CLINICAL OPERATIONS AND DOCUMENT MANAGEMENT Challenges of risk-based monitoring and how to achieve data integration from disparate sources Adaptive Trial Design - quick adaptation of new study designs to reduce the cost of clinical trials and flexibility to respond to new drug supply requirements Digital and site-less trials or digital patients and innovative ways to engage and inform patients Moving towards patient-focused endpoints, patient-reported outcomes, patient-centric trials Automation in clinical trial operations - using technology to increase productivity in Clinical Trial Supplies, Clinical Trial Logistics, Clinical Supply Operations, Clinical Labelling & Packaging TMF, etmf and innovations in document management Artificial Intelligence and Machine Learning in document management MEDICAL AFFAIRS AND SCIENTIFIC COMMUNICATION - ADVANCES IN THE SUPPORT OF A CHANGING HEALTHCARE SYSTEM Improved engagement with healthcare professionals and clinicians Medical Affairs value and cross-functional collaboration with healthcare professionals and patients Reputation management in the era of social media Adopting new technologies in scientific communication Risk-minimisation materials and Medical Information role in education Impact of compliance rules on ability to communicate on medical matters with stakeholders Presenting valid scientific information about vaccines in louder and best understandable way I 5
6 Abstract Topics NOVEL DATA SOURCES: WHERE WILL THEY COME FROM AND HOW WILL THEY ENABLE IMPROVED HEALTHCARE Developing a common data sharing model Case studies in applying artificial intelligence or machine learning in industry or within other stakeholders (regulators, payers, healthcare providers) Putting big data into practice call for examples EMA-HMA Big Data Task force update RWE/RWD use in health care and regulatory decision making AI based solutions to health care issues automation vs innovation what may deep learning add? Data Ethics including data ownership, sharing, trust, privacy and transparency Blockchain as a new tool in healthcare Data use to support development of new therapies Case Study- 3D printing of drugs how does this match with traditional drug development- a new challenge REGULATORY CMC AND PRODUCT QUALITY - ADVANCES IN MANUFACTURE, QUALITY AND SUPPLY Blockchain and other technologies in technical development / manufacturing 3D printing of medicines and its impact on industry, regulators and dispensers Digitalisation of quality and manufacturing processes Shorter supply chains for future therapies: point of care manufacturing and other examples Recent developments within ICH Quality topics Increasing quality standards in manufacturing in the rest of the world: impact on Europe s manufacturing competitiveness FUTURE REGULATION OF DEVICES, COMBINATION PRODUCTS AND DIGITAL Taking stock of the MDR and IVDR implementation Software as a treatment first experiences Companion diagnostics to enable more precise prescribing do they save money? Medical device surveillance and its impact in Europe and globally Evidence generation and assessment for devices Regulatory system changes needs to allow for approval of combination products Use of apps and impact on patient reported outcomes Value-based healthcare for medical device and imaging companies Regulatory approval of combination products under MDR and IVDR: Medicine Authority and Notified Body readiness and revised systems REGIONAL UPDATES AND EU INSIGHTS PROFESSIONAL DEVELOPMENT 1. Regional/Country Updates Eurasia (including Russia) Turkey Japan China ICMRA WHO Middle East Africa 2. Brussels Public Health Agenda for 2025 Women in leadership Increasing diversity in the organisation Leaders of tomorrow Career development From functional expertise to broader management and leadership Patient-centric drug development from bench to bedside changing organisational approaches I 6
7 Speak at Submit an Abstract Deadline: 10 June 2019 Get Involved. We are looking for global, interdisciplinary, cross-functional content with real-world applications. DIA invites you to submit presentation, session and short course abstracts for DIA Europe in Brussels, March You may submit more than one. Abstracts should fall under one of the topics detailed on the following pages. Session Abstract (75 mins) A session abstract is delivered lecture-style from the podium. The abstract author acts as session chair to coordinate efforts in recruiting speakers and manage the session (including the facilitation of question and answers from the audience). PowerPoint presentations are required. Presentation (20 mins) A presentation abstract is a presentation covering a specific topic area, and the speaker is the abstract author. Workshop (60 or 75 mins) A workshop abstract is designed for hands-on learning with a focus on application. The abstract author is considered the workshop chair and ensures the workshop provides onsite learning in the form of activities or demonstrations, including handouts. Forum (60 mins) A forum abstract is designed for panel interaction and attendee engagement. The abstract author acts as forum chair, recruiting panel participants and ensuring good representation/diversity in their selection. PowerPoint presentations are not required. Short Course (180 mins) A Short Course is a hands-on, interactive learning experience for a group of A Half Day Short Course consists of 3 hours of instruction. The short course will have a lead instructor and no more than one co-instructor. How to maximise the probability of your abstract being accepted Abstracts will be selected by the DIA Europe Programme Committee. Focus your abstracts on the proposed topics in this flyer. If your abstract clearly does not fit, submit it as a hot topic/stand-alone presentation or session Your abstract should be as clear and as detailed as possible to enable the theme leaders to make a judgement on its suitability for the programme Abstracts must be non-promotional and non-commercial in order to be considered If you have any questions about abstract submission, please the DIA Europe team: Basel@diaglobal.org How to Submit an Abstract All abstracts have to be submitted online at The deadline for submitting abstracts is Monday, 10 June 2019 I 7
EU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More information'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint
'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint STOA workshop - European Parliament, 10 January 2019 Presented
More informationReflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation
Reflection Paper on synergies between regulatory and HTA issues DG SANTE Unit B4 Medical products: safety, quality, innovation STAMP meeting, 28 June 2016 Outline Aim of the Reflection Paper Drafting process
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationBiomedical Innovation Has Science Overtaken the System?
Adaptive Pathways for Transformative Medicinal Products. A New Paradigm with the Enhanced Application of Real-World Evidence? ISPOR 20 th Annual European Congress, Glasgow, Scotland Issue Panel 21, Wednesday,
More informationSecurity and Risk Assessment in GDPR: from policy to implementation
Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationAndalusian Agency for Health Technology Assessment (AETSA)
Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction
More informationEMA experience with the review of digital technology proposals in medicine development programmes
EMA experience with the review of digital technology proposals in medicine development programmes 3rd Industry Stakeholder Platform on R&D support, 18 May 2018 Francesca Cerreta, Scientific Advice An agency
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationAuthors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry
Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL
More informationThe EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki
The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationDigital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
More informationIntegrated Scientific Advice Workshop: ISPOR Glasgow
Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationAsia Conference Singapore
Fujitsu World Tour 2017 Asia Conference Singapore Human Centric Innovation: Digital Co-Creation Yoshikuni Takashige Vice President, Marketing Strategy and Vision Fujitsu Limited Fujitsu Technology and
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationHealth Innovations in Horizon 2020: the framework programme for research and innovation ( )
Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General
More informationDigital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationRADIOLOGY August 2017
USA EUROPE CHINA BRAZIL The current challenges faced by a Radiologist Too many patients 38% 45% 47% 53% Long working hours 36% 40% 50% 52% Troubleshooting IT and technical issues 14% 23% 28% 33% Limitations
More informationOur position. ICDPPC declaration on ethics and data protection in artificial intelligence
ICDPPC declaration on ethics and data protection in artificial intelligence AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issues. It aims to ensure
More informationMapping of HTA in Europe " Regulatory and Reimbursement Atlas"
CIRS- Centre for Innovation in Regulatory Science 1 CONSENSUS TRUST ACCESS Mapping of HTA in Europe " Regulatory and Reimbursement Atlas" Tina Wang Manager, HTA Programme twang@cirsci.org 20 May 2016 Brussels,
More informationCultural Evolution Is the future in our own hands?
Cultural Evolution Is the future in our own hands? Dr Paul Litchfield - Chief Medical Officer, BT Group Laura Collins - Carer and East Belfast ICP member Colette Goldrick - NI Director, APBI Dr Anne Kilgallen
More informationDisruption Ahead. The Healthcare Industry in the next decade. EY Digital Health and Human Services. LASA Tri-State Conference.
Disruption Ahead The Healthcare Industry in the next decade EY Digital Health and Human Services LASA Tri-State Conference 6th February 2017 EY 2 Over the next ten years, you will have at your disposal
More informationFinn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark
EUnetHTA European network for Health Technology Assessment DATABASES, REGISTRIES AND OTHER DATA CAPTURE TOOLS: HOW CAN WE AVOID MULTIPLICITY AND CREATE AN INTEGRATED DATA-CAPTURE APPROACH ALONG THE PRODUCT
More informationBuilding quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?
Workshop on Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA? 2 nd & 3 rd December 2013 Sheraton Heathrow Airport Hotel, UK PROGRAMME Organisers:
More informationNHS Next Stage Review: Innovation
NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused
More informationENCePP Work Plan
EMA/150117/2014 ENCePP Secretariat European Network of Centres for Pharmacoepidemiology and Pharmacovigilance European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Adopted by the ENCePP
More informationENCePP Work Plan
EMA/231507/2012 ENCePP Secretariat European Network of Centres for Pharmacoepidemiology and Pharmacovigilance European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Adopted by the ENCePP
More informationEnpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency
Enpr EMA European Network of Paediatric Research at the European Medicines Agency Enpr-EMA European Network of Paediatric Research at the European Medicines Agency An agency of the European Union Enpr
More informationEU Cooperation on Health Technology Assessment
Strategy for EU Cooperation on Health Technology Assessment Strategy for EU cooperation on Health Technology Assessment (HTA) The HTA Network is a voluntary network, set up by Directive2011/24 (article
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationEU Research Integrity Initiative
EU Research Integrity Initiative PROMOTING RESEARCH INTEGRITY IS A WIN-WIN POLICY Adherence to the highest level of integrity is in the interest of all the key actors of the research and innovation system:
More informationEnabling ICT for. development
Enabling ICT for development Interview with Dr M-H Carolyn Nguyen, who explains why governments need to start thinking seriously about how to leverage ICT for their development goals, and why an appropriate
More informationLife Sciences Regulatory
Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP
More informationBringing Technology and Product Development Best Practices Together for Successful Innovation
Bringing Technology and Product Development Best Practices Together for Successful Innovation April 18 19, 2018 * Boston Convention & Exhibition Center Preliminary Agenda AGENDA AT A GLANCE Day One Wednesday,
More informationAIMed Artificial Intelligence in Medicine
Medical Intelligence and Innovation Institute (MI3) Presents The First International Multidisciplinary Symposium on Artificial Intelligence in Medicine: Analytics and Algorithms, Big Data, Cloud and Cognitive
More informationNational Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs
National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs Jeff Shuren Director, CDRH Food and Drug Administration Center for Devices and Radiological Health 1 We face a critical public
More informationRegulatory Science For Innovation
Regulatory Science For Innovation Fergal Donnelly European Commission Directorate-General for Research & Innovation Directorate 'Industrial Technologies' Unit 'Advanced Materials and Nanotechnology' The
More informationInter-Association Task Force
Inter-Association Task Force Presentation to EMA Workshop Prevention of Drug Shortages Based on Quality and Manufacturing Issues 9 th October 2015 1 Topics for Today Background and history of task force
More informationResponse to the Western Australian Government Sustainable Health Review
Response to the Western Australian Government Sustainable Health Review On behalf of Australia s digital health community, HISA commends this submission to the Sustainable Health Review Panel, and wish
More informationEDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS
EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution
More informationThe impact of rapid technological change on sustainable development
15-17 January 2019, Vienna The impact of rapid technological change on sustainable development Shamika N. Sirimanne Director, Division on Technology and Logistics UNCTAD 2018-2019 CSTD Intersessional Panel
More informationDigitalisation of the medicines lifecycle: challenges and opportunities
Digitalisation of the medicines lifecycle: challenges and opportunities Anthony Rowe Data & Knowledge Management SGG www.efpia.eu Three trends in technology today Ubiquity of the Internet Three trends
More informationOMCL Network of the Council of Europe GENERAL DOCUMENT
OMCL Network of the Council of Europe GENERAL DOCUMENT PA/PH/OMCL (09) 87 4R OMCL Network support for the implementation of the CoE MEDICRIME Convention Full document title and reference How the OMCL Network
More informationDigital Health and Introducing Innovative Technologies in the NHS
Digital Health and Introducing Innovative Technologies in the NHS 22 September 2015 NATIONAL INFORMATION BOARD techuk.org @techuk #techuk Digital Health and introducing innovative technologies in the NHS
More informationHealth Innovation Manchester
Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationWHO Regulatory Systems Strengthening Program
WHO Regulatory Systems Strengthening Program MVP RHT RSS CRS www.who.int Minimal capacity met Eligibility for vaccine PQ WHO listed NRAs WHO NRA 5 step capacity building Development of NRA benchmarking
More informationSustainable Society Network+ Research Call
Sustainable Society Network+ Research Call Call for Pilot Studies and Challenge Fellowships Closing date: 17:00 on 31 st October2012 Summary Applicants are invited to apply for short- term pilot study
More informationPriorities for medical research in the UK
Priorities for medical research in the UK Sir Leszek Borysiewicz Medical Research Council The Foundation for Science and Technology, 20 May 2009 MRC mission Encourage and support high-quality research
More informationWebinar IMI2 Call 13 Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
Webinar IMI2 Call 13 Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice 14 December 2017 10:30 CET Agenda How to use GoToWebinar Catherine
More informationWebinar IMI2 - Call 15 Digital endpoints in neurodegenerative and immunemediated
Webinar IMI2 - Call 15 Digital endpoints in neurodegenerative and immunemediated diseases 18.07.2018 Agenda How to use GoToWebinar Catherine Brett, IMI Introduction Colm Carroll, IMI The Call topic Vaibhav
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More information6 & 7 December. current concepts for. Smart health in orthopaedics. congress.
9th edition 6 & 7 December 2018 congress Trans-atlantic current concepts for Smart health in orthopaedics Congress Guide 2018 It is our pleasure to announce the 9 th IMUKA Congress The European Current
More informationEvidence for Effectiveness
Evidence for Effectiveness Developing a standards framework for digital health innovations Digitally empowering people to manage their health and care October 2018 The issue NHS England programmes Apps
More informationHorizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission
Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The
More informationEU businesses go digital: Opportunities, outcomes and uptake
Digital Transformation Scoreboard 2018 EU businesses go digital: Opportunities, outcomes and uptake February 2018 Internal Market, Industry, Entrepreneurship and SMEs Executive summary Conditions and outcomes
More informationNew Approaches to Safety and Risk Management
New Approaches to Safety and Risk Management 15 18 May 2011 The 3rd DIA China Annual Meeting, Bejjin, China Ayman Ayoub MD MSC (med) Safety Surveillance & Risk Management Pfizer Disclaimer The views/opinions
More informationVirtual Clinical Trials: Challenges and Opportunities
Virtual Clinical Trials: Challenges and Opportunities November 28 29, 2018 National Academy of Sciences Building, Lecture Room 2101 Constitution Ave. NW, Washington, DC 20418 Background: The cost of bringing
More informationMedical Device Usability Engineering. Product and Service Design Innovation Consultancy
Medical Device Usability Engineering Product and Service Design Innovation Consultancy Delivering Meaningful Innovation PDD services Our integration of multiple disciplines means we offer a comprehensive
More informationTable Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D08 - HAI Europe Newsletter (EN)... 7 D01 - HAI Europe leaflet (EN)... 7 D02 - Briefing Papers and statements
More informationSupporting Innovation through Regulation and Science
Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers
More informationImplementation of Systems Medicine across Europe
THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0 The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation
More informationMinistry of Industry. Indonesia s 4 th Industrial Revolution. Making Indonesia 4.0. Benchmarking Implementasi Industri 4.0 A.T.
Ministry of Industry s 4 th Industrial Revolution Making 4.0 Benchmarking Implementasi Industri 4.0 A.T. Kearney Industry 4.0 initiative is the global trend in the manufacturing industry End of 18 th century
More informationSmart devices. How to unlock their potential in the real world. Tobias Handschuh, Ernst & Young
Smart devices How to unlock their potential in the real world Tobias Handschuh, Ernst & Young Smart devices How to unlock their potential in the real world Smart injectors situation today Expectations
More informationChanging landscape - changing paradigms
IP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE? Department director Øyvind Melien Assessment interventions, Norwegian Institute
More informationEuropean Network for Health Technology Assessment (EUnetHTA) Joint Action 3
European Network for Health Technology Assessment (EUnetHTA) Joint Action 3 Zoe Garrett, Senior Technical Adviser Lead WP7 National Implementation and Impact National Institute for Health and Care Excellence
More informationWFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN ( )
WFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN (2016-2019) Hosted by The China Association for Science and Technology March, 2016 WFEO-CEIT STRATEGIC PLAN (2016-2019)
More informationtechnologies, Gigaom provides deep insight on the disruptive companies, people and technologies shaping the future for all of us.
September 21-23 Austin, Texas LEADER S SUMMIT Partner Kit As the leading global voice on emerging technologies, Gigaom provides deep insight on the disruptive companies, people and technologies shaping
More informationClinical Forum Attendee Sample Job Titles
Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.
More informationIP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE?
IP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE? Department director Øyvind Melien Assessment interventions, Norwegian Institute
More informationTool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases
Tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases In 2017 the multi-stakeholder initiative was set up to: Facilitate a shared understanding of the
More informationGeneral Questionnaire
General Questionnaire CIVIL LAW RULES ON ROBOTICS Disclaimer This document is a working document of the Committee on Legal Affairs of the European Parliament for consultation and does not prejudge any
More informationResearch and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research
Page 1 of 9 Research and Innovation Strategy and Action Plan 2012 2015 UPDATE Advancing knowledge and transforming lives through education and research Executive Summary As the enterprise university, Plymouth
More informationTHE GSMA PRESENTS MINISTERIAL PROGRAMME
THE GSMA PRESENTS MINISTERIAL PROGRAMME 25-27 FEBRUARY 2019 2 Welcome to the Ministerial Programme The GSMA s prestigious Ministerial Programme brings together the most influential telecommunications leaders
More informationHealth Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI
Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI SAMED, Annual Conference, May 29 th 2014 From «Does
More informationThe Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program
The Future of Patient Data The Global View Key Insights Berlin 18 April 2018 The world s leading open foresight program Context Over a 6 month period, 12 expert discussions have taken place around the
More informationHealth Care Analytics: Driving Innovation
Health Care Analytics: Driving Innovation Jonathan Woodson, MD, MSS, FACS Director, Institute for Health System Innovation and Policy jwoodson@bu.edu Driving Innovation in Health Care 2 Organizational
More informationIssues in Emerging Health Technologies Bulletin Process
Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The
More informationAviation Data Symposium June 2018 Berlin, Germany
Aviation Data Symposium 19-20 June 2018 Berlin, Germany The second edition of IATA Aviation Data Symposium (ADS) will take place on 19 20 June 2018 at the InterContinental Hotel in Berlin, Germany. Harness
More informationHealth Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities
Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and
More informationTackling AMR A Cross Council Initiative
Tackling AMR A Cross Council Initiative AMR an ecological /systems level perspective AMR Funders Forum (AMRFF) Made up of representatives from the research councils, governmental bodies and charities Strategic
More informationLSIF Convenor s Summary Report to CTI
2016/SOM1/CTI/054 Agenda Item: 11 LSIF Convenor s Summary Report to CTI Purpose: Consideration Submitted by: LSIF PG Chair First Committee on Trade and Investment Meeting Lima, Peru 28-29 February 2016
More informationNovember 18, 2011 MEASURES TO IMPROVE THE OPERATIONS OF THE CLIMATE INVESTMENT FUNDS
November 18, 2011 MEASURES TO IMPROVE THE OPERATIONS OF THE CLIMATE INVESTMENT FUNDS Note: At the joint meeting of the CTF and SCF Trust Fund Committees held on November 3, 2011, the meeting reviewed the
More informationFrontier Technology Futures: Support to the DFID Bangladesh Country Office
Frontier Technology Futures: Support to the DFID Bangladesh Country Office Team of 1-2 Strategists Total of approx. twenty-seven (27) days input. This piece of work is a pilot, and if successful, would
More informationTechnology and Innovation in the NHS Scottish Health Innovations Ltd
Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop
More informationthe SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
More informationInnovating to survive, collaborating to thrive 2017 Pharmaceutical R&D leader survey
Innovating to survive, collaborating to thrive 2017 Pharmaceutical R&D leader survey Contents Foreword 01 Analysis of survey findings 02 Drivers influencing R&D priorities 02 Strong headwinds affecting
More informationIEEE IoT Vertical and Topical Summit - Anchorage September 18th-20th, 2017 Anchorage, Alaska. Call for Participation and Proposals
IEEE IoT Vertical and Topical Summit - Anchorage September 18th-20th, 2017 Anchorage, Alaska Call for Participation and Proposals With its dispersed population, cultural diversity, vast area, varied geography,
More informationFinal Minutes of EMA/EUnetHTA meeting
4 June 2013 EMA/297283/2013 14 May 2013 chaired by Hans-Georg Eichler and Finn Børlum Kristensen Role Chairs Participants Name Hans-Georg Eichler and Finn Børlum Kristensen EMA: Peter Arlett, Michael Berntgen,
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationThe IEEE Global Initiative on Ethics of Autonomous and Intelligent Systems. FairWare2018, 29 May 2018
The IEEE Global Initiative on Ethics of Autonomous and Intelligent Systems FairWare2018, 29 May 2018 The IEEE Global Initiative on Ethics of Autonomous and Intelligent Systems Overview of The IEEE Global
More information